Ontology highlight
ABSTRACT: Background
Observational studies suggest greater height is associated with increased ovarian cancer risk, but cannot exclude bias and/or confounding as explanations for this. Mendelian randomisation (MR) can provide evidence which may be less prone to bias.Methods
We pooled data from 39 Ovarian Cancer Association Consortium studies (16,395 cases; 23,003 controls). We applied two-stage predictor-substitution MR, using a weighted genetic risk score combining 609 single-nucleotide polymorphisms. Study-specific odds ratios (OR) and 95% confidence intervals (CI) for the association between genetically predicted height and risk were pooled using random-effects meta-analysis.Results
Greater genetically predicted height was associated with increased ovarian cancer risk over
SUBMITTER: Dixon-Suen SC
PROVIDER: S-EPMC5931085 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature